Study: Prazosin inhibits endocytic sorting

September 13, 2012

In a study just published in Proceedings of the National Academy of Sciences, Dr Ulrike Eggert et al. demonstrated that the drug Prazosin inhibits endocytic sorting.

They implicate the G protein-coupled dopamine receptor D3 and the membrane transport complex coatomer COPI in this process, proposing  a new biological role for .

This work shows an interesting off-target effect of Prazosin, used in the clinic as an antagonist of α1-adrenic receptors (a sub-family of G ), providing a useful tool for the further study of endosome dynamics.

Explore further: Review: Blood pressure drug effective for treating PTSD-related nightmares

More information: www.pnas.org/content/109/31/12485.full.pdf+html

Related Stories

Recommended for you

Fighting the aging process at a cellular level

September 22, 2016

It was about 400 BC when Hippocrates astutely observed that gluttony and early death seemed to go hand in hand. Too much food appeared to 'extinguish' life in much the same way as putting too much wood on a fire smothers ...

Tattoo therapy could ease chronic disease

September 22, 2016

A temporary tattoo to help control a chronic disease might someday be possible, according to scientists at Baylor College of Medicine who tested antioxidant nanoparticles created at Rice University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.